<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="176810">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00793676</url>
  </required_header>
  <id_info>
    <org_study_id>4171</org_study_id>
    <nct_id>NCT00793676</nct_id>
  </id_info>
  <brief_title>Asthma, Inflammation and G Protein-coupled Receptors (GPCR)</brief_title>
  <official_title>G Protein Coupled Receptor (GPCR)Signature as Biomarker of Chronic Pulmonary Inflammatory Diseases and of Therapeutic Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Agency, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The G protein-coupled receptors (GPCRs) are a family of proteins expressed at the cell
      membrane. They are composed of 380 members involved in the important functions of the
      organism and are privileged therapeutic targets.Their expression is highly modulated
      depending on the metabolic state of the cells, in particular in pathological situations.our
      study proposes to determine whether GPCR expression modulation could be used as a biomarker,
      either prognostic or diagnostic, of treatments.To do so , the investigators will determine
      the expression profile of the 380 human GPCRs in human blood cell samples in two chronic
      inflammatory pulmonary diseases : asthma and COPD (chronic obstructive pulmonary disease ) .
      These have opposed inflammatory infiltrates : asthma is associated with eosinophil and Th2
      lymphocyte infiltration whereas COPD shows neutrophils and macrophages within the airways
      with a Th1 lymphocytic population. The GPCR signature (transcriptomic) will be determined on
      total white blood cells as well as on isolated mono- and poly-nuclear populations obtained
      from healthy subjects and patients selected at the asthma or COPD consultation. The
      expression profiling analysis will reveal sub-groups of GPCRs whose expression is modified
      in disease. The specificity of the variation of expression of these biomarker
      sub-populations will be determined, by a study recruiting a hundred patients and controls
      per disease on this restraint number of genes. The outcomes of the project will lead to
      establish GPCR &quot;identity cards&quot; for these chronic inflammatory diseases, which might
      therefore be used as diagnostic or prognostic biomarkers to follow the evolution of a
      disease or the efficacy of a given treatment. In addition, detailed analysis of the
      identified GPCRs will lead to propose new therapeutic targets for inflammatory diseases.
      This study has therefore the objective of validating GPCRs as potential biomarkers for
      inflammatory diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multicentre non-randomized
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>differential expression of GPCRs</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">310</enrollment>
  <condition>Asthma</condition>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>A= Asthma</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B= COPD</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>C= Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>spirometry</intervention_name>
    <arm_group_label>A= Asthma</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood test</intervention_name>
    <arm_group_label>A= Asthma</arm_group_label>
    <arm_group_label>B= COPD</arm_group_label>
    <arm_group_label>C= Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Asthma group

          -  COPD group

          -  Control group

        Exclusion Criteria:

          -  Patients with infection or inflammatory diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Romain Kessler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Romain Kessler, MD</last_name>
    <phone>0369550377</phone>
    <phone_ext>0033</phone_ext>
    <email>romain.kessler@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital</name>
      <address>
        <city>Colmar</city>
        <zip>68024</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean philippe Oster, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean Philippe Oster, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pascal Chanez</name>
      <address>
        <city>Marseille</city>
        <zip>13008</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal Chanez, MD</last_name>
      <phone>04 91 74 46 30</phone>
      <phone_ext>0033</phone_ext>
      <email>pascal.chanez@univmed.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arnaud Bourdin, MD</last_name>
    </contact>
    <investigator>
      <last_name>Arnaud Bourdin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Antoine Magnan</name>
      <address>
        <city>Nantes</city>
        <zip>44035</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine Magnan, MD</last_name>
      <phone>02 40 16 52 35</phone>
      <phone_ext>0033</phone_ext>
      <email>antoine.magnan@nantes.inserm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital, Strasbourg, France</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <lastchanged_date>September 29, 2015</lastchanged_date>
  <firstreceived_date>November 17, 2008</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GPCR expression</keyword>
  <keyword>transcriptomic</keyword>
  <keyword>white blood cells</keyword>
  <keyword>diagnostic</keyword>
  <keyword>Control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
